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The neural pathways through which central serotoner-
gic systems regulate food intake and body weight re-
main to be fully elucidated. We report that serotonin,
via action at serotonin1B receptors (5-HT1BRs), modu-
lates the endogenous release of both agonists and an-
tagonists of the melanocortin receptors, which are
a core component of the central circuitry controlling
body weight homeostasis. We also show that seroto-
nin-induced hypophagia requires downstream activa-
tion of melanocortin 4, but not melanocortin 3, recep-
tors. These results identify a primary mechanism
underlying the serotonergic regulation of energy bal-
ance and provide an example of a centrally derived sig-
nal that reciprocally regulates melanocortin receptor
agonists andantagonists in asimilarmanner toperiph-
eral adiposity signals.
Introduction
Serotonin (5-hydroxytryptamine, 5-HT) analogs have
been widely developed as weight-loss agents, based
largely on early observations of the strong inverse rela-
tionship between 5-HT levels and food consumption
(Breisch et al., 1976; Garattini et al., 1986; Goudie
et al., 1976; Samanin et al., 1980). 5-HT does not cross
the blood-brain barrier, and it is synthesized in both
the periphery and brain from the essential amino acid
tryptophan. It is speculated that 5-HT-induced appetite
suppression is predominantly mediated by central 5-HT
pathways, although the mechanism has not been fully
defined. It is well established that within the brain the ar-
cuate nucleus of the hypothalamus (ARC) plays an im-
portant role in energy homeostasis (Cone, 2005; Elm-
quist et al., 1999; Gropp et al., 2005; Luquet et al.,
2005) and is thus a strong candidate to function as a cen-
tral nucleus subserving 5-HT-induced hypophagia.
The ARC contains two distinct populations of neurons:
one expressing the endogenous anorectic melanocortin
receptor agonist, a-melanocyte stimulating hormone (a-
MSH), and the other expressing the endogenous orexi-
genic melanocortin receptor antagonist, agouti-related
protein (AgRP) (Elias et al., 1998; Hahn et al., 1998; Bro-
berger et al., 1998). Both a-MSH and AgRP are potent
modulators of food intake and body weight and are re-
ciprocally regulated by peripheral signals, such as the
adipose tissue-derived hormone leptin and the gastroin-
testinal hormone ghrelin (Ahima et al., 1999; Cowley
et al., 2003; Elias et al., 1999). We hypothesize that mela-
nocortin pathways are also differently regulated by cen-
trally derived signals, such as 5-HT, and that melanocor-
tin circuitry is a primary mechanism underlying 5-HT’s
effects on energy balance. Consistent with this hypothe-
sis, the 5-HT reuptake inhibitor/5-HT stimulated release
compound d-fenfluramine and 5-HT2CR agonists acti-
vate a-MSH-containing neurons (Heisler et al., 2002).
However, it is not known whether 5-HT pathways, in con-
cert, regulate the signaling of AgRP-containing neurons,
the mechanism of this prospective regulation, or
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5-HT-induced hypophagia.
A 5-HT receptor that is positioned to affect ARC AgRP
activity is the 5-HT1BR (rodent homolog to human 5-
HT1DbR) (Bruinvels et al., 1994; Makarenko et al., 2002).
This receptor has been strongly implicated in 5-HT-in-
duced hypophagia. Specifically, high-affinity 5-HT1BR
agonists produce substantial reductions in food intake,
effects that are attenuated by pharmacological block-
ade or genetic inactivation of 5-HT1BRs (Halford and
Blundell, 1996; Lee et al., 1998; Lee and Simansky,
1997; Lucas et al., 1998). 5-HT1BRs are Gi-coupled to
inhibit adenylate cyclase and are expressed on 5-HT
presynaptic terminals and postsynaptic terminals. 5-
HT1BRs are also expressed on nonserotonergic pre-
synaptic terminals where they regulate the release of
other neurotransmitters, such as g-amino butyric acid
(GABA) (Chadha et al., 2000; Stanford and Lacey,
1996). We hypothesize that 5-HT1BRs are expressed
both on AgRP-containing neurons and on the AgRP in-
hibitory axonal projections to POMC-containing neu-
rons (Cowley et al., 2001, 2003; Roseberry et al., 2004).
If this is the case, then 5-HT action at ARC 5-HT1BRs
would lead to a decrease in the release of the endoge-
nous melanocortin receptor (MCR) antagonist and an
increase in the release of the endogenous MCR agonist
at downstream MCR-expressing target sites.
Within the brain, a-MSH and AgRP compete for action
at Mc3rs and Mc4rs (Cone, 2005). Of these receptors, the
Mc4rs have been demonstrated to produce the most po-
tent effects on food intake, body weight, energy expen-
diture, and insulin action (Fan et al., 2000; Huszar et al.,
1997). In fact, dysregulation of Mc4rs is associated with
the most common monogenic cause of human obesity
identified thus far (Farooqi et al., 2000; Vaisse et al.,
1998). Consistent with this finding, Mc4rs are expressed
in multiple central regions associated with energy ho-
meostasis, such as the paraventricular nucleus of the hy-
pothalamus and the dorsal motor nucleus of the vagus
(Kishi et al., 2003; Liu et al., 2003; Mountjoy et al.,
1994). If 5-HT requires melanocortin pathways to regu-
late energy balance, then downstream action at the
Mc4rs is a likely downstream component of this circuitry.
In the present study, we examined whether 5-HT path-
ways are anatomically positioned to differently regu-
late the signaling of central melanocortin agonist- and
antagonist-containing neurons. We assessed whether
this regulation is achieved via action at the 5-HT1BR,
the only Gi-coupled 5-HT receptor associated with sati-
ety known to be expressed in the ARC that acts as both
a postsynaptic receptor and heteroreceptor. Finally, we
determined whether Mc4rs are a necessary downstream
target of 5-HT agonist-induced hypophagia. The find-
ings presented here further define the pathways under-
lying 5-HT’s effects on energy homeostasis, a neuro-
transmitter system that has been a major target for
obesity treatment.
Results
5-HT1BRs Are Expressed in NPY/AgRP-Containing
Neurons
Transgenic mice expressing tau-sapphire green fluores-
cent fusion protein (GFP) under the control of a NPYpromoter/enhancer were used to identify ARC cells ex-
pressing NPY/AgRP for anatomical and physiological
studies (NPY-GFP mice) (Cowley et al., 2003; Pinto
et al., 2004; Roseberry et al., 2004). We confirmed that
GFP is exclusively expressed in AgRP mRNA-containing
neurons (99.5%) throughout the rostral caudal extent of
the ARC in NPY-GFP mice using in situ hybridization
histochemistry (ISHH) with a 35S-labeled riboprobe for
AgRP mRNA coupled with immunohistochemistry (IHC)
for GFP (GFP-IR) (n = 5; Figures 1A and 1B). These data
indicate that ARC cells expressing GFP contain AgRP
mRNA.
Next, by generating a 5-HT1BR riboprobe that identi-
fied 5-HT1BR mRNA in mice with ISHH, we investigated
whether 5-HT1BRs are positioned to affect AgRP activ-
ity. Consistent with earlier reports in rats (Bonaventure
et al., 1998; Bruinvels et al., 1994), we observed that 5-
HT1BR mRNA is abundantly expressed in the wild-type
mouse brain, with particularly high levels in the olfactory
tubercle, caudate putamen, cortex, hypothalamus (in-
cluding the ARC; Figure 1C), hippocampal formation,
thalamus, dorsal raphe, and cerebellum (n = 5). Using
double labeling for 35S-5-HT1BR and GFP-IR in NPY-
GFP mice, we determined that approximately one-third
of ARC 5-HT1BR-expressing neurons were GFP-IR pos-
itive and that one-sixth of ARC GFP-IR neurons were 5-
HT1BR positive (n = 3; Figure 1D). These findings indicate
that 5-HT1BRs are anatomically positioned to affect the
activity of a subpopulation of ARC AgRP neurons.
5-HT Terminals Are in Close Apposition
to NPY/AgRP Neurons
We performed light and electron microscopic analysis to
determine whether 5-HT terminals establish synaptic
contacts with AgRP-containing neurons. Using dual-la-
bel IHC in brain tissue from NPY-GFP mice, we found
that 5-HT boutons are in direct apposition both to ARC
GFP cell bodies and to proximal and distal dendrites
(n = 3–5; Figures 1E–1H). Specifically, we observed that
approximately one-third (mean 6 SEM, 34 6 5, out of
100) of GFP-positive profiles were contacted by 5-HT-
IR putative axon terminals in NPY-GFP mice. Electron
microscopic analysis confirmed that 5-HT axon termi-
nals established synapses on these neurons (Figures 1I
and 1J). Additionally, close proximity of 5-HT and GFP
boutons was noted presynaptic to unidentified ARC peri-
karya (Figure 1E). These observations suggest that 5-HT
may produce a dual effect on AgRP neurons, affecting
both neuronal activity and the release of products from
the axon.
Effect of 5-HT and 5-HT1BR Agonists on Activity
of NPY/AgRP and a-MSH Neurons
We used an electrophysiological approach to establish
the functional relevance of our anatomical observations.
Using GFP-labeled cells in ARC slices of NPY-GFP
mouse brains, we observed a trend of bath-applied
5-HT (30 mM) hyperpolarization of GFP neurons [8.1 6
7.1 mV, n = 3, t(2) = 1.99, n.s.; Figure 2A], and this effect
was reversible with 5-HT washout. These findings sug-
gest that 5-HT likely reduces the release of AgRP at
downstream central sites. Consistent with mediation of
5-HT action at 5-HT1BRs, selective 5-HT1BR agonists hy-
perpolarized NPY-GFP neurons (Figure 2A). Specifically,
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241Figure 1. NPY/AgRP-Containing ARC Neurons Coexpress 5-
HT1BRs and Display Close Apposition to 5-HT Axon Terminals
(A) Schematic of representative level of the ARC illustrating that
99.5% of neurons containing GFP-IR colocalized with 35S-labeled
AgRP (red stars) in mice expressing tau-sapphire green fluorescent
fusion protein under the control of a NPY promoter (NPY-GFP).
Some neurons were only labeled by 35S-AgRP (black pluses). (B)
Representative photograph illustrating neurons containing GFP-IR
(brown cytoplasm) colocalized with 35S-labeled AgRP (cluster of
black grains) in the ARC of NPY-GFP mice. (C) Neurons containing
35S-labeled 5-HT1BR (white grains) under darkfield illumination are
expressed in the ARC as determined with ISSH in wild-type mice
(n = 5). (D) Dual-labeling for IHC and ISSH revealed that ARC neurons
expressing GFP-IR (brown cytoplasm) colocalized with 35S-labeled
5-HT1BR (black grains) in NPY-GFP mice (n = 3). Using dual fluores-
cence for GFP (green profiles) and 5-HT (red profiles), both putative
axodendritic ([E and G], white arrows) and axosomatic ([F and G],
white arrows) contacts between 5-HT-IR boutons and GFP-NPY
cells in the ARC were revealed. (H) Dual-IHC labeling further illus-
trated that proximal dendrites from GFP-IR cells (brown reaction
product) were in close proximity to 5-HT-IR boutons (black reaction
product). (I) Correlated electron microscopy demonstrated that this
is a direct connection, indicating synaptic interaction (wide black ar-
row) between this 5-HT bouton and the GFP dendrite. (J) In further
clarifying that these membrane specializations are indeed synaptic
in nature, postembedding labeling of 5-HT using 5 nm gold-conju-
gated secondary antisera showed clear synaptic membrane special-
ization (wide black arrow) between a 5-HT-immunopositive bouton
(narrow black arrow) and the perikaryal membrane of a GFP neuron
in the ARC. Scale bar represents 20 mm in (B) and also applies to (D),the selective 5-HT1BR agonists CP94253 [200 nM, n = 5,
t(4) = 3.52, p < 0.05] and CP93129 [200 nM, n = 3, t(2) =
3.20, p < 0.09] hyperpolarized the membrane potential
of identified GFP neurons (10 of 14 assessed; Figures
2A and 2B). In the GFP-NPY neurons that were sponta-
neously firing action potentials (7 of 10 GFP neurons
tested), 5-HT1BR agonists hyperpolarized 6 of these 7
neurons with an accompanying 78% 6 9% decrease in
spontaneous firing frequency. The selective 5-HT1BR
antagonist SB224289 (200 nM) prevented significant hy-
perpolarization induced by CP94253 (200 nM) alone, re-
sulting in a net change in membrane potential of 0.65 6
1.0 mV (n = 4; Figure 2A). These data suggest that 5-HT
reduces AgRP neuron activity via action at 5-HT1BRs.
A strong inhibitory GABAergic projection exists be-
tween NPY/AgRP neurons and proopiomelanocortin
(POMC, the uncleaved precursor of a-MSH) cells in the
ARC (Cowley et al., 2001; Roseberry et al., 2004). Be-
cause 5-HT1BRs are expressed on nonserotonergic
axon terminals and have been demonstrated to affect
GABA release in other brain regions (Chadha et al.,
2000; Stanford and Lacey, 1996), we hypothesized that
5-HT may also affect POMC activity via 5-HT1BRs ex-
pressed on inhibitory NPY/AgRP terminals projecting
to POMC neurons in the ARC. To examine this, we ex-
ploited transgenic mice expressing GFP under the tran-
scriptional control of the POMC gene promoter. We
measured inhibitory postsynaptic currents (IPSCs)
onto GFP neurons in hypothalamic slices from POMC-
GFP mice (Cowley et al., 2001). 5-HT [30 mM, n = 6,
t(5) = 6.98, p < 0.05] and 5-HT1BR agonists CP94253
[100 nM, n = 5, t(4) = 2.84, p < 0.05] and CP93129
[100 nM, n = 12, t(11) = 11.08, p < 0.05] reversibly re-
duced IPSCs in GFP-labeled POMC neurons by approx-
imately one-third (Figures 2C–2F). Of note, the effect of
CP94253 and CP93129 on IPSC frequency onto POMC
neurons was seen at a lower drug concentration than
the effect on NPY/AgRP neuron membrane potential.
This is likely due to technological issues related to the
difficulty of reliably quantifying small changes in mem-
brane potential, whereas small changes in IPSC fre-
quency can be more reliably assessed. Taken together,
the results presented here indicate that 5-HT, via action
at 5-HT1BRs, both reduces the likelihood of release of
AgRP and facilitates the release of a-MSH at down-
stream target sites.
Melanocortin Pathways Are Required for 5-HT
Probes to Promote Satiety
We next assessed the effect of the 5-HT indirect agonist
and antiobesity compound d-fenfluramine (d-fen) in
mice with constitutive ectopic expression of the endog-
enous MCR antagonist, agouti peptide (Ay mice). It is
well established that 5-HT probes may suppress food in-
take by either advancing satiety or by interfering with
food intake (e.g., by enhancing sedation), since 5-HT
modulates a wide variety of behaviors and physiological
processes. For example, Vickers and colleagues
demonstrated that 3.0 mg/kg of d-fen specifically
250 mm in (C); scale bar in (E) and (H) represents 10 mm and also ap-
plies to (F) and (G); scale bar represents 1 mm in (I) and (J). 3v, third
ventricle; ME, median eminence, ARC, arcuate nucleus of the hypo-
thalamus; 5-HT, serotonin; GFP, green fluorescent protein.
Neuron
242Figure 2. 5-HT and 5-HT1BR Agonists Hyper-
polarize ARC NPY/AGRP Neurons and De-
crease Inhibitory Synaptic Input onto POMC
Neurons
(A) Bath application of CP94253 (200 nM; n =
6) significantly hyperpolarized ARC GFP-NPY
neurons; the effect was blocked by coappli-
cation with the selective 5-HT1BR antagonist
SB224289 (200 nM; n = 4). CP93129 (200
nM; n = 3) and 5-HT (30 mM; n = 3) also hyper-
polarized ARC NPY neurons. Data are ex-
pressed as mean 6 SEM.
(B) Example of raw data showing that
CP94253 (200 nM) hyperpolarized and de-
creased the spontaneous activity of a single
ARC NPY neuron. Mean of membrane po-
tential 5 min prior to agonist application =
251.4 mV; during agonist application (3.2
min) = 253.7 mV; peak effect 9 min into
washout = 257.7 mV; recovery 30 min into
washout = 252.8 mV. Firing frequency prior
to agonist application = 0.2 Hz; during ag-
onist = 0.15 Hz; during peak hyperpolariza-
tion = 0.007 Hz; during partial recovery =
0.05 Hz.
(C) CP94253 (100 nM; n = 5), CP93129
(100 nM; n = 12), and 5-HT (30 mM; n = 6) sig-
nificantly decreased the frequency of sponta-
neous IPSCs onto ARC POMC neurons. Data
are expressed as mean 6 SEM.
(D) Examples of raw data showing IPSCs be-
fore, during, and after bath application of
200 nM CP93129. Inset demonstrates repre-
sentative kinetics of GABA-induced ionic conductances superimposed at a higher magnification (peak current is 65 pA in 400 ms window) before
agonist application (black) and during peak effect (red).
(E) CP93129 (100 nM) reversibly decreases the inhibitory synaptic input onto POMC neurons (n = 12). Shaded region corresponds to time of drug
application. Data are expressed as mean 6 SEM.
(F) Cumulative frequency histogram demonstrating the reversible effect of CP93129 (100 nM) on IPSC frequency onto ARC POMC neurons
[Baseline versus CP93129 t(34) = 3.14, p < 0.01; Baseline versus Peak Effect t(55) = 11.77, p < 0.001; Baseline versus Reversal t(46) = 0.81,
n.s.]. *p < 0.05, **p < 0.01, ***p < 0.001 (compared to baseline or hypothesized 0). Data are expressed as mean 6 SEM.reduced food intake by advancing the behavioral satiety
sequence, whereas higher doses (e.g., 10–30 mg/kg) in-
duced behaviors like stereotypy that disrupt feeding
(Vickers et al., 1999). Lee and colleagues also reported
that higher concentrations of d-fen (5.6–30 mg/kg) inter-
rupt normal feeding-behavior patterns in wild-type mice
(Lee et al., 2004).
To investigate the role of melanocortin pathways se-
lectively in 5-HT-induced satiety, we treated young
lean male Ay mice and weight-matched wild-type litter-
mates (n = 10 per genotype) with a low dose of d-fen (1.5
mg/kg, i.p.), a dose that advances satiety (3.0 mg/kg,
i.p.), and a dose that enhances resting/inactive behavior
(6.0 mg/kg, i.p.). D-fen significantly reduced 1 hr chow
mash intake at the onset of the dark cycle in wild-type
mice [F(3,18) = 3.91, p < 0.05, post hoc saline versus
d-fen 3.0 and 6.0 mg/kg; Figure 3A]. In contrast,Ay litter-
mates did not alter 1 hr chow mash intake following any
dose of d-fen except that which promotes resting and
consequently disrupts feeding [F(3,18) = 3.79, p < 0.05,
post hoc d-fen 6.0 mg/kg versus all other doses;
Figure 3B]. The induction of behaviors that compete
with feeding at higher concentrations of 5-HT probes
is likely associated with the lack of 5-HT receptor selec-
tivity, which confounds the interpretation of the specific
pathways modulating 5-HT’s effects on satiety.
We therefore investigated the mechanism of 5-HT-
induced satiety via action at the 5-HT1BRs using theselective 5-HT1BR agonist CP94253 (Ki 5-HT1BR = 2,
5-HT1AR = 89, 5-HT2CR = 860, 5-HT1DR = 49, and 5-
HT2AR = 1600 nM; Koe et al., 1992). This compound en-
hances satiety and produces a behavioral profile com-
parable to prefeeding in rodents (Halford and Blundell,
1996; Lee and Simansky, 1997). Specifically, CP94253
reduces both meal size and meal duration without
Figure 3. Response of Young, Lean Wild-Type Mice and Ay Litter-
mates to the Classic Serotonergic Hypophagic Compound d-fen
(A) D-fen reduced 1 hr chow mash intake at the onset of the dark cy-
cle in wild-type mice (n = 10, bw = 16–19 g, baseline mash intake =
0.97 6 0.10 g) compared to saline treatment at a dose associated
with satiety (3.0 mg/kg, i.p.) and a dose associated with the induc-
tion of behaviors that compete with feeding (6.0 mg/kg, i.p.).
(B) In contrast, 1 hr chow mash intake was not affected in Ay litter-
mates (n = 10, bw = 16–20 g, baseline mash intake = 1.05 6 0.12 g)
treated with any dose of d-fen except that which is associated
with the induction of behaviors that disrupt normal feeding patterns
(6 mg/kg, i.p.). **p < 0.01, *p < 0.05 (compared to saline treatment).
Data are expressed as mean 6 SEM.
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243Figure 4. Hypophagic Effects of 5-HT1BR Agonist CP94253 Are Independent of Alterations in Active Behavior and Are Mediated via Action at
5-HT1BRs
(A) Selective 5-HT1BR agonist CP94253 (4.0, 8.0, 16.0 mg/kg, i.p.) dose-dependently reduced 6 hr dark cycle powdered chow intake in adult male
C57BL/6 mice (n = 16, bw = 20–26 g, baseline 6 hr chow intake = 2.09 6 0.4 g) assessed in Comprehensive Lab Animal Monitoring System
(CLAMS) chambers. Post hoc analyses revealed that 8.0 mg/kg and 16.0 mg/kg significantly reduced food intake compared to saline treatment.
(B) CP94253-induced hypophagia was independent of alterations in locomotor activity (baseline 6 hr activity = 24376 633 counts/hr), which was
concominantly collected in the CLAMS chambers.
(C) Hypophagia elicited by CP (CP94253; 8.0 mg/kg, i.p.) was abolished by pretreatment with the 5-HT1BR antagonist SB (SB224289; 2.5 mg/kg,
s.c.) in adult male 129/Sv-ter mice (n = 9, bw = 21–26 g) tested in the homecage following 18 hr food deprivation. Post hoc analyses demonstrated
that CP94253 significantly reduced 1 hr chow pellet intake compared to saline treatment and that this effect was reversed by SB22489 pretreat-
ment. **p < 0.01, *p < 0.05 (compared to saline treatment). Data are expressed as mean 6 SEM.altering oral motor efficiency compared to saline treat-
ment in rats (Lee and Simansky, 1997). As a first step,
we sought to confirm that CP94253 (4.0, 8.0, 16.0
mg/kg, i.p.) does not produce generalized effects on ac-
tive/inactive behaviors in our hands. Male C57BL/6 mice
(n = 16) were assessed during the first 6 hr of the dark
cycle in comprehensive laboratory animal monitoring
chambers, which concomitantly measure food intake
and locomotor/horizontal activity. CP94253 (8.0, 16.0
mg/kg, i.p.) specifically reduced 6 hr powdered chow
intake compared to saline [F(5,15) = 2.10, p < 0.05;
Figure 4A] without significantly altering normal dark-
cycle behavioral activity (ANOVA n.s.; Figure 4B).
We confirmed that CP94253-induced hypophagia was
dependent on 5-HT1BR stimulation by pretreating mice
with the 5-HT1BR antagonist SB224289 (Ki 5-HT1BR =
6.3 nM and >100-fold greater affinity over other 5-
HT1Rs, 5-HT2Rs, 5-HT4R, 5-HT6R, and 5-HT7R; Selkirk
et al., 1998). When administered alone, SB224289 (2.5
mg/kg, s.c.) did not significantly alter 1 hr chow pellet in-
take (Figure 4C). However, pretreatment with SB224289
abolished the hypophagic effect of 8.0 mg/kg CP94253
[F(3, 24) = 4.02, p < 0.05, post hoc saline + CP94283 ver-
sus SB224289 + CP94253; Figure 4C]. Together, these
baseline studies confirm that CP94253 selectively de-
creases food intake via action at 5-HT1BRs, data which
are in accord with previous findings (Halford and Blun-
dell, 1996; Lee and Simansky, 1997; Lee et al., 2002).
To examine the importance of downstream MCRs in
the hypophagic effect of 5-HT acting at 5-HT1BRs, we
compared the response to CP94253 in three groups of
weight-matched mice; Ay mice, ob/ob mice bearing
a mutation in the leptin gene, and wild-type littermates
(n = 8 per genotype). Consistent with that shown above,
CP94253 (8.0, 16.0 mg/kg, i.p.) significantly reduced 6 hr
chow mash intake in young wild-type [F(2,14) = 6.68, p <
0.01; Figure 5A] and ob/ob control mice [F(2,14) = 6.97,
p < 0.01; Figure 5B], while, in contrast, the same doses
of CP94253 did not alter food intake in Ay mice (ANOVA
n.s.; Figure 5C). We next assessed the effect of CP94253
in older obese weight-matched mice with and without
genetic alterations in melanocortin circuitry (n = 7–8
per genotype). Similar to data presented in mice in the
young, nonobese state, CP94253 (8.0, 16.0 mg/kg, i.p.)significantly reduced 6 hr consumption of 58% high-
fat diet (HFD) in dietary-induced obese (DIO) mice
[F(2,14) = 6.68, p < 0.01; Figure 5D] and ob/ob control
mice [F(2,14) = 6.14, p < 0.05; Figure 5E], but did not
affect food intake in Ay mice (ANOVA n.s.; Figure 5F).
These findings demonstrate that the selective 5-HT1BR
agonist CP94253 requires downstream activation of
MCRs to promote hypophagia in both the lean and
obese state.
Mc4rs Are Downstream Targets of Selective 5-HT1BR
Agonist
We refined our model by hypothesizing that intact Mc4rs
are a necessary downstream component of energy bal-
ance pathways engaged by 5-HT. To investigate this, we
examined the efficacy of satiety-inducing doses of se-
lective 5-HT1BR agonist CP94253 (8.0 mg/kg, i.p.) and
the 5-HT indirect agonist d-fen (3.0 mg/kg, i.p.) on
chow pellet intake in strains of traditionalMc4r knockout
(KO) mice (Huszar et al., 1997), Mc3r KO mice (Butler
et al., 2000), and wild-type littermates 6 hr following
the onset of the dark cycle (n = 10–12 per genotype).
Consistent with that presented above, CP94253 signifi-
cantly reduced food intake compared to saline in wild-
type mice [t(11) = 5.0, p < 0.001; Figure 6A]. Supporting
a role for the Mc4rs in this effect, Mc3r KO mice dis-
played a similar level of hypophagia in response to
CP94253 [t(11) = 6.5, p < 0.001; Figure 6B] as wild-type
littermates, while, in contrast, Mc4r KOs were insensi-
tive to the effects of this compound (t test n.s.;
Figure 6C). We further explored the role of Mc4rs in 5-
HT-induced satiety by investigating whether Mc4r KOs
were responsive to a more general 5-HT probe, the clas-
sic anorectic d-fen. Virtually identical data were ob-
tained with satiety-associated doses of d-fen and the
selective 5-HT1BR agonist CP94253. Specifically, d-fen
significantly decreased food intake compared to saline
treatment in both wild-type mice [t(11) = 5.7, p < 0.001;
Figure 6D] and Mc3r KO mice [t(11) = 9.5, p < 0.001;
Figure 6E], but did not alter feeding in Mc4r KO mice
(t test n.s.; Figure 6F).
To further clarify that activation of the Mc4rs is a pri-
mary mechanism through which 5-HT, via 5-HT1BRs, af-
fects feeding behavior, we examined the hypophagic
Neuron
244Figure 5. CP94253-Induced Hypophagia Re-
quires Melanocortin Signaling
Selective 5-HT1BR agonist CP94253 (8.0 and
16.0 mg/kg) significantly reduced 6 hr dark
cycle chow mash intake in young lean (A)
wild-type littermate (n = 8, bw = 18–23 g,
baseline mash intake = 5.0 6 0.54 g) and (B)
age- and weight-matched ob/ob control
mice (n = 8, bw = 18–22 g, baseline mash in-
take = 6.2 6 0.43 g), but was not effective in
altering food intake in (C) Ay mice (n = 8,
bw = 16–23 g, baseline mash intake = 4.3 6
0.59 g). Similarly, CP94253 (8.0 and 16.0
mg/kg) significantly reduced 6 hr dark cycle
high-fat diet intake (HFD) in murine models
of obesity (D) DIO (n = 8, bw = 30–38 g, base-
line HFD intake = 1.4 6 0.37 g) and (E) ob/ob
mice (n = 7, bw = 40–44 g, baseline HFD in-
take = 2.56 0.42 g), but did not affect feeding
behavior in (F) Ay mice (n = 7, bw = 30–35 g,
baseline HFD = 1.5 6 0.33 g). DIO mice were
littermates of Ay and ob/ob mice maintained
on the HFD postweaning. **p < 0.01, *p <
0.05 (compared to saline treatment). Data
are expressed as mean 6 SEM.efficacy of CP94253 and d-fen in another independently
generated Mc4r null strain. We created this Mc4r null al-
lele by inserting a transcriptional blocker (loxTB) se-
quence 50 of the Mc4r coding sequence (Balthasar
et al., 2005). Mirroring data obtained with Ay mice and
Mc4r KOs, older obese loxTB Mc4r mice were insensi-
tive to hypophagic effects of CP94253 (8.0 mg/kg, i.p.)
on 6 hr chow pellet intake [wild-type t(7) = 2.91, p <
0.05; loxTB Mc4r t test, n.s.; Figures 7A and 7B]. We
next investigated whether results obtained in young
lean Ay and Mc4r KO mice treated with d-fen would be
mimicked in young lean loxTB Mc4r mice. Specifically,
wild-type littermate and weight- and age-matched
loxTB Mc4r null mice were treated with saline or d-fen
(3.0 mg/kg i.p.), and subsequent intake of chow mash
was measured for the next hour at the onset of the
dark cycle (n = 8 per genotype). Like other mice with
Mc4r disruption, loxTB Mc4r null mice did not respond
to the hypophagic effect d-fen, whereas wild-type litter-
mates significantly reduced food intake in response tod-fen [wild-type t(7) = 2.82, p < 0.05; loxTB Mc4r t test,
n.s.; Figures 7C and 7D].
The consistent finding that 5-HT agonist-induced hy-
pophagia is blocked in mice with disrupted Mc4r func-
tion, whether Ay, Mc4r KO, or loxTB Mc4r, in either the
lean or obese state, and when presented with palatable
chow mash (Figures 3A, 3B, 5A–5C, 7C, and 7D), stan-
dard chow pellet (Figures 6A–6F, 7A, and 7B), or high-
fat (Figures 5D–5F) diet, ascertains that the Mc4r is
a necessary component of 5-HT regulation of satiety.
These data establish that Mc4rs, but not Mc3rs, are crit-
ical downstream targets in 5-HT satiety pathways.
Discussion
Despite the established clinical utility of 5-HT-derived
drugs in the induction of weight loss, the responsible
mechanisms have remained obscure. We present evi-
dence from a range of neuroanatomical, electrophysio-
logical, transgenic, and behavioral studies that the centralFigure 6. 5-HT Compounds Require Mc4rs,
but Not Mc3rs, to Reduce Food Intake
Selective 5-HT1BR agonist CP94253 (8.0
mg/kg, i.p.) significantly reduced 6 hr dark cy-
cle chow pellet intake in young lean (A) wild-
type (n = 12, bw = 20–22 g, baseline chow in-
take = 3.36 0.17 g) and (B)Mc3r KO mice (n =
12, bw = 20–22 g, baseline chow intake =
3.3 6 0.33 g), but did not alter food intake in
(C) Mc4r KO littermates (n = 12, bw = 20–22
g, baseline chow intake = 3.7 6 0.14 g). Sim-
ilar results were obtained following d-fen (3.0
mg/kg). D-fen significantly reduced 6 hr dark
cycle chow pellet intake in (D) wild-type and
(E) Mc3r KO mice, but had no effect
on food intake in (F) Mc4r KO littermates.
***p < 0.001 (compared to saline treatment).
Data are expressed as mean 6 SEM.
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stimulation of hypophagia. We demonstrate that5-HT, via
5-HT1BRs, both inhibits AgRP neuronal activity and re-
duces inhibitory postsynaptic currents onto POMC neu-
rons. Complementing these data, we recently reported
that 5-HT and 5-HT2CR agonists stimulate POMC neurons
(Heisler et al., 2002). The data presented here show that 5-
HT differentially regulates melanocortin agonist- and an-
tagonist- containing neurons and that downstream acti-
vation of Mc4rs is a primary mechanism through which
5-HT affects food intake. Figure 8 illustrates a proposed
model of a mechanism through which 5-HT regulates en-
ergy balance via melanocortin pathways.
5-HT is a biogenic amine that is derived from the es-
sential dietary amino acid tryptophan. Therefore, the dy-
namic interplay between nutritional intake and synthesis
of 5-HT indicates that 5-HT, like other adiposity and met-
abolic cues, is inextricably linked to energy intake (Fern-
strom and Wurtman, 1972). However, 5-HT also affects
many other instinctual drives and behaviors that may in-
terfere with feeding. It is therefore important to distin-
guish whether 5-HT compounds reduce food intake
specifically by promoting satiety. For example, early
pharmacological studies indicated that compounds
such as d-fen and mCPP (a high-affinity 5-HT2C/1B ago-
nist) at lower concentrations specifically advanced sati-
ety, but at higher concentrations, enhanced resting and
by consequence suppressed active behaviors like feed-
ing. As more selective 5-HTR compounds have become
available, such as the 5-HT1BR agonist CP94253, behav-
ioral profiles more consistent with satiety at a range of
doses have been found. Here we report that melanocor-
tin pathways are a downstream target of d-fen and
CP94253 at concentrations previously demonstrated
to advance satiety.
Studies of targeted deletion of specific 5-HTRs indi-
cate that 5-HT1BRs and 5-HT2CRs are the most critically
involved 5-HTRs in the modulation of energy balance
Figure 7. 5-HT Compounds Require Mc4rs to Reduce Food Intake
Selective 5-HT1BR agonist CP94253 (8.0 mg/kg, i.p.) significantly re-
duced 6 hr dark cycle chow pellet intake in (A) wild-type mice (n = 8,
bw = 26–31 g), but did not alter food intake in (B) obese LoxTB Mc4r
littermates (n = 8, bw = 32–53 g). Similarly, d-fen (3.0 mg/kg) signifi-
cantly reduced 60 min dark cycle chow mash intake in young lean
(C) wild-type mice (n = 8, bw = 17–19 g), but had no effect on food
intake in (D) LoxTB Mc4r littermates (n = 8, bw = 17–19 g). *p < 0.05
(compared to saline treatment). Data are expressed as mean6 SEM.(Lucas et al., 1998; Tecott et al., 1995). Specifically, de-
letion of either the 5-HT1BR or 5-HT2CR gene promotes
enhanced body weight and attenuates responses to
classic anorectic 5-HT compounds like d-fen (Bouw-
knecht et al., 2001; Lucas et al., 1998; Tecott et al.,
1995). Here we investigated the mechanism through
which 5-HT1BR activation affects ingestive behavior.
We demonstrated that 5-HT fibers make axo-somatic
contacts with GFP-labeled NPY/AgRP neurons in the
ARC and that a subpopulation of GFP-IR neurons ex-
pressed 5-HT1BRs. It is important to note that an accu-
rate determination of the degree of coexpression is dif-
ficult to obtain as a result of the technological limitations
frequently encountered with dual-labeling with 35S-la-
beled 5-HTR riboprobes and IHC. However, it is clear
that a subpopulation of ARC NPY/AgRP neurons coex-
press 5-HT1BR mRNA. We used an electrophysiological
approach to investigate the functional relevance of
these anatomical findings. Both 5-HT and 5-HT1BR ago-
nists hyperpolarized GFP-NPY neurons, effects that
could be blocked by coapplication with a selective 5-
HT1BR antagonist. These data suggest that NPY/AgRP
neurons are 5-HT responsive, via action at 5-HT1BRs.
5-HT terminals also make synaptic contacts with
POMC neurons and stimulate these cells. We recently
reported that 5-HT2CRs were coexpressed with POMC
neurons and that 5-HT2CR agonists dose-dependently
depolarized POMC neurons (Heisler et al., 2002). Here
we show that 5-HT fibers make additional axo-axonal
contacts with NPY/AgRP terminals. Some NPY/AgRP
terminals are GABAergic and make contacts with
nearby POMC neurons, affecting POMC neuronal activ-
ity (Cowley et al., 2001; Roseberry et al., 2004). 5-HT1BR
agonists, like CP93129, have been demonstrated to re-
duce GABA release, an effect that is inhibited by 5-
HT1BR antagonist pretreatment (Chadha et al., 2000).
We report that 5-HT and selective 5-HT1BR agonists,
like CP93129, significantly and consistently reduced
Figure 8. Schematic Diagram of Proposed 5-HT Sites of Action on
Melanocortin Pathways
5-HT hyperpolarizes and inhibits AgRP neurons and decreases an
inhibitory drive onto POMC cells by activation of 5-HT1BRs. 5-HT
also activates POMC neurons via activation of 5-HT2CRs. This leads
to reciprocal increases in a-MSH release and decreases in AgRP re-
lease at Mc4r in target sites.
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246inhibitory postsynaptic currents onto POMC neurons.
This reciprocal action on inhibitory and excitatory inputs
into melanocortin neurons is reminiscent of that estab-
lished for peripheral signals, such as leptin and ghrelin
(Cowley et al., 2001; Roseberry et al., 2004).
To investigate whether regulation of melanocortin cir-
cuitry is critical to the effects of 5-HT on satiety, we ex-
amined the anorectic efficacy of 5-HT compounds in ro-
dents with melanocortin receptor blockade. We recently
reported that pretreatment with the Mc3/Mc4r antago-
nist SHU9119 attenuated the anorectic efficacy of the
antiobesity compound d-fen (Heisler et al., 2002). Here
we show that Mc3r KO mice treated with anorectic
doses of d-fen and the 5-HT1BR agonist CP94253 re-
sponded similarly to wild-type littermates, suggesting
that Mc3rs are unlikely to be a downstream target of 5-
HT-induced hypophagia. In contrast, the anorectic ef-
fect of both d-fen and CP94253 was abolished in Ay,
Mc4r KO mice, and loxTB Mc4r null mice, strongly indi-
cating that a primary mechanism of 5-HT-induced sati-
ety is via action at downstream Mc4rs.
Here we present data in support of 5-HT regulation of
activity of ARC neurons expressing the endogenous
Mc4r antagonist AgRP and agonist a-MSH. However,
the ARC is likely not the only site of 5-HT-melanocortin
circuitry integration. Clear support for a brainstem locus
of 5-HT hypophagic action has been provided by re-
searchers such as Simansky and colleagues (Lee
et al., 1998) and Grill and colleagues (Grill et al., 1997).
For example, infusion of CP93129 into the lateral para-
brachial nucleus (lPBN) dose-dependently reduced
food intake (Lee et al., 1998). The lPBN is a key site in-
volved in autonomic regulation, and we recently re-
ported Mc4r expression in this region (Kishi et al.,
2003; Liu et al., 2003). It is possible that 5-HT may
make axo-axonal contacts with POMC and AgRP termi-
nals arising from the ARC (or other inhibitory inputs) that
form synaptic connections with Mc4r-expressing cells
in sites such as the IPBN. 5-HT activation of 5-HT1BR
heteroreceptors expressed on these terminals may re-
duce inhibitory postsynaptic currents onto Mc4r-ex-
pressing neurons. This potential of 5-HT1BR-Mc4r inter-
action outside of the ARC warrants investigation.
It is also important to note that other hypothalamic
pathways are affected within our model. Specifically, if
5-HT affects POMC and AgRP neuronal activity, then
the release of neuropeptides coexpressed in these neu-
rons, such as cocaine and amphetamine-regulated tran-
script (CART) and NPY, respectively, should also be af-
fected. Both CART and NPY alter food intake, and
affecting the release of these neuropeptides may aug-
ment, interfere with, or have no effect on the results ob-
tained with 5-HT agonists (Kristensen et al., 1998; Lam-
bert et al., 1998). It is therefore striking that blockade of
a single downstream target, the Mc4rs, is sufficient to
render ineffective the 30%–50% reduction of food intake
produced by classic 5-HTR agonists. These data were
consistently observed, in both lean and obese mice pre-
sented with various diets. We conclude that reciprocal
regulation of upstream hypothalamic melanocortin ago-
nist- and antagonist-containing neurons and subse-
quent downstream activation of Mc4rs underlies the
food-reducing properties of centrally derived classic
appetite-regulating neurotransmitter 5-HT.Experimental Procedures
Subjects
All mice were individually housed (except transgenic mice express-
ing green fluorescent protein, which were group housed) with food
and water available ad libitum in a light- (12 hr on/12 hr off) and tem-
perature-controlled environment (21.5ºC–22.5ºC). Adult male trans-
genic mice expressing GFP specifically in NPY (Cowley et al., 2003;
Pinto et al., 2004; Roseberry et al., 2004) or POMC neurons (Cowley
et al., 2001) were used for the electrophysiology experiments. Adult
male NPY-GFP mice were used for the neurohistochemical analysis.
In feeding studies, young mice (5–8 weeks old) were weight-
matched with littermates. Older obese mice (3–5 months old) were
weight-matched with other murine models of obesity, such as die-
tary-induced obese mice (wild-type littermates of Ay and ob/ob
mice, Jackson Laboratories) maintained on a 58% fat diet post-
weaning (Research Diets) and ob/ob mice (B6.V-Lepob/J, Jackson
Laboratories). Mice with disrupted melanocortin function were
male Ay mice (B6.Cg-Ay/J, Jackson Laboratories), Mc4r KO (Huszar
et al., 1997), loxTB Mc4r null mice (Balthasar et al., 2005), and Mc3r
KO mice (Butler et al., 2000). All mice were on a C57BL/6 back-
ground, except loxTB Mc4r mice, which were on a mixed 129Sv
and C57BL/6 background. Additional control wild-type feeding
studies were performed in male 129/Sv-ter mice (University of Sus-
sex colony).
Neurohistochemical Analysis
Tissue Preparation and Histology
Brain tissue was collected from adult male C57BL/6 and heterozy-
gous NPY-GFP mice. Under deep anesthesia (350 mg/kg chloral hy-
drate, i.p.), mice were perfused transcardially with diethel pyrocar-
bonate (DEPC)-treated 0.9% saline followed by 10% neutral
buffered formalin or 4% paraformaldehyde. Brains were removed,
immersed in the same fixative for 4 hr, and then in 20% sucrose in
DEPC-treated phosphate-buffered saline (PBS pH 7.0) for 18–36 hr
at 4ºC. Brains were sectioned coronally on a freezing sliding micro-
tome at 25 mm (in situ hybridization histochemistry) or on a vibratome
at 60 mm (light and fluorescence microscopy).
Single-Label In Situ Hybridization Histochemistry
Visualization of 5-HT1BR mRNA in the mouse brain (n = 5) was
achieved with ISHH using similar methods to those previously de-
scribed (Elias et al., 1999; Liu et al., 2003). A 5-HT1BR riboprobe
was generated using a 199-nt segment of the 30-untranslated region
of rat 5-HT1BR as template. Plasmids were linearized by digestion
with NotI (antisense) or SalI (sense). The riboprobe was subjected
to in vitro transcription using a T3 polymerase (Ambion) in the pres-
ence of 35S-labeled UTP in accordance with the manufacturer’s pro-
tocols. The 35S-labeled 5-HT1BR cRNA probe was diluted to 10
6
cpm/ml in a hybridization solution (Elias et al., 1999; Liu et al.,
2003). Free-floating ISSH was performed using standard methods
reported by our laboratory (Liu et al., 2003) in brain tissue from
C57BL/6 mice (n = 4). Tissue was then mounted onto Superfrost
slides, dehydrated in graded concentrations of ethanol, air-dried,
and dipped in NTB2 photographic emulsion (Kodak). Slides were
stored for 4 weeks at 4ºC and then developed with D-19 Developer
and Fixer (Kodak). Controls for specificity were performed by (1) hy-
bridization following tissue pretreatment with RNase, (2) hybridiza-
tion with the sense 5-HT1BR riboprobe, and (3) comparing distribu-
tion of hybridization signal with published rodent 5-HT1BR mRNA.
Dual-Label ISHH and Immunohistochemistry
Concurrent visualization of GFP and 5-HT1BR mRNA or AgRP mRNA
was performed by combining ISHH and IHC, using methods previ-
ously reported (Liu et al., 2003). Briefly, free-floating brain sections
of NPY-GFP mice (n = 3–4) were processed for ISSH as previously
described (Liu et al., 2003) using 35S-labeled 5-HT1BR or
35S-labeled
AgRP riboprobes. While tissue was still free-floating, IHC was then
performed to identify GFP-producing brain sites. Specifically, tissue
was rinsed in 0.3% hydrogen peroxide (Sigma) in PBS, blocked in
3% normal donkey serum (Jackson ImmunoResearch Laboratories
Inc.) in 0.25% Triton X-100 in PBS (PBT), incubated in a GFP rabbit
primary antiserum (Molecular Probes, 1:20,000) in PBT, bathed
with a biotinylated donkey anti-rabbit IgG (Jackson ImmunoRe-
search Laboratories Inc., 1:1000) secondary antibody in PBT, im-
mersed in a solution of avidin-biotin complex (Vectastain Elite ABC
5-HT Reciprocally Regulates Melanocortin Neurons
247Kit; Vector Laboratories, 1:500) in PBS, and finally rinsed in a solution
of 0.04% DAB (Sigma) and 0.01% hydrogen peroxide in PBS. Brain
sections were then mounted onto Superfrost slides (Fisher Scien-
tific), dehydrated, delipidated, air-dried, and dipped in NTB2 photo-
graphic emulsion (Kodak). Slides were stored in light-tight boxes at
4ºC for 10 days (35S-labeled AgRP) or 4 weeks (35S-labeled 5-HT1BR)
and then developed with D-19 Developer and Fixer (Kodak). Deter-
mination of cells expressing both GFP-IR and 35S-labeled AgRP or
35S-labeled 5-HT1BR was performed using criteria previously de-
scribed (Elias et al., 1999; Liu et al., 2003). Briefly, clusters of grains
(the hybridization signal) more than 3-fold background, overlying
and conforming to the shape of a cell containing the GFP-IR signal,
were considered a double-labeled cell. Adjacent series of sections
were stained with thionin for the identification of nuclear boundaries.
Photographs and schematic images were produced using a Zeiss
Axioskop 2 mot plus with an interface with a Pentium III computer.
Schematic Images were drawn using Canvas software.
Dual-IHC
Dual-IHC was performed to examine 5-HT inputs onto GFP-IR cell
bodies and processes. To visualize dual-fluorescence imaging of
5-HT and GFP, IHC was performed as previously described (Liu
et al., 2003; Pinto et al., 2004). Briefly, tissue from NPY-GFP mice
(n = 3) was incubated with primary rabbit antiserum for 5-HT (Immu-
nostar Inc., 1:5000) for 24 hr. A secondary anti-rabbit IgG labeled
with Alexa Fluor 594 (Molecular Probes) was then applied, and
a red fluorescent reaction product was obtained. After labeling for
5-HT, tissue was processed for GFP-IR. Tissue was incubated in
mouse anti-GFP antiserum (Molecular Probes, 1:1000) for 24 hr at
4ºC and then immersed in solution containing a secondary antibody
(horse anti-mouse IgG conjugated with FITC diluted 1:50 in PBS
Dako) for 2 hr. A green reaction product was obtained. Controls
for specificity were performed by incubating sections in antisera
that had been preadsorbed with the specific antigen (50 mg/ml of di-
luted antisera) and by omitting the incubation with the primary anti-
sera step. Sections were mounted onto slides, ethanol-dehydrated,
cleared in xylenes, and coverslipped with Vectashield mounting me-
dium (Vector Labs). The dual fluorescence was assessed using fluo-
rescence filters on a Zeiss Axiostar microscope equipped with an
Axioplan 2 color camera. Putative contacts were detected under
1003 magnification. Images were captured using a computer inter-
face with the Zeiss Axiostar microscope and were displayed in
panels using Photoshop software.
Electron Microscopic Immunocytochemistry
To examine light and electron microscopic analyses of 5-HT inputs
onto ARC NPY/AgRP neurons, we combined pre- and postembed-
ding immunolabeling of GFP and 5-HT (postembedding labeling of
large core vesicles with 5 nm gold-conjugated secondary antisera)
to investigate the ultrastructural relationship between GFP and 5-HT.
First, tissue was processed for IHC in a similar manner to that de-
scribed above. Specifically, brain tissue from NPY-GFP mice (n = 5)
was blocked in 3% normal donkey serum (Jackson ImmunoRe-
search Laboratories Inc.) in PBS for 1 hr. Next, tissue was incubated
in a 5-HT rabbit primary antiserum (Immunostar, 1:25,000) in PBS for
12–18 hr. Sections were rinsed in PBS and then immersed in a bioti-
nylated donkey anti-rabbit IgG (Jackson ImmunoResearch Labora-
tories Inc., 1:1000) secondary antibody for 1 hr. Tissue was rinsed
in PBS and then incubated in a solution of ABC (Vectastain Elite
ABC Kit; Vector Laboratories, 1:500) dissolved in PBS for 1 hr. Visu-
alization of 5-HT was achieved using a nickel-DAB reaction (15 mg of
DAB, 0.12 mg of glucose oxidase, 12 mg of ammonium chloride,
600 ml of 0.05M nickel ammonium sulfate, and 600 ml of 10% b-D-glu-
cose in 30 ml of PBS) for 10–30 min, resulting in a dark blue-black re-
action product. After several rinses in PBS, the sections were further
incubated in mouse anti-GFP antiserum (Molecular Probes, 1:1000)
for 24 hr at 4ºC and then immersed in a secondary antibody (horse
anti-mouse IgG diluted 1:50 in PBS, Dako) for 2 hr. Finally, tissue
was incubated in rabbit peroxidase-anti-peroxidase (PAP; 1:100 in
PBS, Dako) for 2 hr. Between each incubation step, the sections
were rinsed (four times for 10 min each) in PBS. The tissue-bound
peroxidase was visualized by a light brown DAB reaction. The colors
of the two reaction products were easily distinguishable, and in sin-
gle-stained material in which one of the primaries was omitted, only
one color was seen. After immunostaining, the sections were thor-
oughly rinsed in PBS and processed for correlated electron micros-copy. After visualization of tissue antigens, sections were wet-
mounted in PBS and examined under the light microscope. Color
photographs of GFP-IR NPY/AgRP cells contacted by putative 5-
HT-immunoreactive axon terminals were captured using computer
interface with the Zeiss Axiostar microscope. Sections were then os-
micated, dehydrated, and embedded in araldite. Blocks were
trimmed using the color picture of previously identified cells and
boutons as a guide. Ribbons of serial ultrathin sections were col-
lected on Formvar-coated single-slot grids and examined under
the electron microscope. In a set of sections, after immunolabeling
of GFP and embedding, ultrathin sections were further immuno-
stained for 5-HT using the antisera described above in dilution of
1:25,000 and using 5 nm gold-conjugated secondary antisera. This
procedure was carried out in accordance with our published proto-
col (Cowley et al., 2001, 2003; Pinto et al., 2004; Horvath and Gao,
2005).
Electrophysiology
Standard electrophysiological techniques were used, as previously
published (Cowley et al., 2001; Heisler et al., 2002). Briefly, under iso-
flurane anesthesia, male mice were rapidly decapitated and the
brain was removed. Coronal hypothalamic slices containing the
ARC were cut at 185 mm on a vibratome under ice-cold, gassed
(95% O2/5% CO2) artificial cerebrospinal fluid (aCSF) of the following
composition (mM): NaCl 126, KCl 2.5, MgCl2 1.2, CaCl2 2.4, NaH2PO4
1.2, NaHCO3 21.4, glucose 11.1 (pH 7.4). Slices were maintained car-
bogenated at room temperature for 1 hr prior to recordings. Whole-
cell patch-clamp recordings were obtained from POMC-GFP or
NPY-GFP ARC neurons at 32ºC6 0.5ºC. For membrane-potential re-
cordings, current-clamp recordings were performed with patch pi-
pettes (2–4 MU) filled with an intracellular solution of the following
composition (mM): K gluconate 128, EGTA 1, KCl 10, MgCl2 1,
CaCl2 0.3, (Mg) ATP 5, (Na)GTP 0.3, HEPES 10 (pH 7.3) (with
NaOH), 290 mOsm. For inhibitory postsynaptic potential recordings,
voltage-clamp recordings were performed with patch pipettes (2–4
MU) filled with a cesium-based intracellular solution of the following
composition (mM): CsCl 140, MgCl2 5, (Mg) ATP 5, (Na)GTP 0.3,
BAPTA 1, HEPES 10 (pH 7.3) (with CsOH), 290 mOsm. Because of
the stochastic firing properties of arcuate NPY neurons, 10 min of
baseline data were recorded for each arcuate neuron prior to drug
application. Only stable cells were treated with drugs. Drugs were
applied at the specified concentrations in the superfusion medium
by gravity for approximately 4 min. Recordings were obtained by
a Axopatch 200B patch-clamp amplifier and analyzed using pClamp
8.0 (Axon Instruments) and MiniAnalysis 5.0 (Synaptosoft, Inc.).
Feeding and Locomotor Studies
Food was removed and drug or vehicle was administered at 45 min
prior to the onset of the dark cycle to ad libitum fed mice (n = 8–12
per genotype in each testing condition). Food was replaced at the
onset of the dark cycle, and subsequent food intake and/or locomo-
tor activity were recorded for the next 1–6 hr. A subset of male wild-
type 129/Sv-ter mice (n = 9) were food deprived for 18 hr, received
saline or 5-HT1BR antagonist pretreatment, and 30 min later received
5-HT1BR agonist treatment. Chow was then provided, and intake
was measured for the next hour. All mice were provided with one
of the following diets: chow pellets available in a hopper above the
cage, high-fat paste diet (58% fat, Research Diets) provided in glass
jars within the cage, chow mash diet (powdered Purina Rodent
Chow and water at 1:1 concentration) provided in plastic jars within
the cage, or powdered laboratory Purina Rodent Chow provided in
the CLAMS apparatus described below. All studies were performed
in the homecage, with the exception of those conducted in the
CLAMS chambers. Each mouse was tested with both drug and
saline, administered in a counterbalanced order, with a minimum
of 3 days between the treatments.
Comprehensive Lab Animal Monitoring System
CLAMS (Columbus Instruments) chambers were used to assess the
effect of CP94253 on acute food intake and locomotor activity.
CLAMS chambers are plexiglass 1 l rectangular cages with a two-
level photobeam array surround for locomotor activity determina-
tion. A spring-loaded grate covered powdered standard laboratory
chow, such that as food is consumed, the grate is lowered. The
feeder is attached to a balance and food intake is recorded in an
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collected and stored in a time-stamped data file. Mice were accli-
mated to the chambers prior to the start of the study, during which
time food intake and body weight was monitored and compared
to homecage conditions. Once stable feeding patterns were evident,
mice underwent the experimental treatment.
Drugs
D-fenfluramine (Sigma), 5-HT (Sigma), CP94253 (Tocris Cookson,
Vernalis Research Ltd, or kindly provided by Phoenix Pharmaceuti-
cals), CP93129 (Tocris Cookson), and SB224289 (Vernalis Research
Ltd or Tocris Cookson) were used. All drugs, except SB224289 (Ver-
nalis Research Ltd) used in in vivo studies, were dissolved in 0.9%
pyrogen-free saline and administered intraperitoneally (i.p.) in a vol-
ume of 10 ml/g of body weight. SB224289 was initially dissolved in
20% of the final volume of PEG400, sonicated for 20 min, and
made up to volume with 10% 2-hydroxypropyl-b-cyclodextrin (Fluka)
in water, and administered subcutaneously (s.c.) in a volume of 4 ml/g
of body weight.
Data Analysis
Behavioral data were collected in a within-subjects design, such that
each mouse acted as its own control. Prior to performing statistical
tests, data were assessed for normality with Shapiro-Wilk’s test us-
ing SPSS PC Advanced Statistics (v. 11.5) software. All data were
normally distributed and were analyzed with either a one-sample t
test (electrophysiology data), dependent t test (for saline and one
drug dose behavioral comparisons), or repeated-measures analysis
of variance (RM ANOVA), followed by Tukey’s post hoc tests (for sa-
line and more than one drug dose behavioral comparisons). For all
analyses, significance was assigned at the p% 0.05 level.
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